{"id":21525,"date":"2023-07-17T08:06:45","date_gmt":"2023-07-17T12:06:45","guid":{"rendered":"https:\/\/medicarereport.org\/?p=21525"},"modified":"2023-07-17T08:06:46","modified_gmt":"2023-07-17T12:06:46","slug":"researchers-turn-to-crispr-to-unlock-one-of-the-trickiest-diseases-to-treat-alzheimers","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=21525","title":{"rendered":"Researchers turn to CRISPR to unlock one of the trickiest diseases to treat: Alzheimer\u2019s"},"content":{"rendered":"\n<p>(By Andrew Joseph for ST<em>A<\/em>T)<\/p>\n\n\n\n<p>When the genome-editing tool CRISPR is thought of as a potential medicine, the targets that first come to mind are diseases like sickle cell or other conditions caused by particular mutations. Use CRISPR to fix that mutation, the idea goes, and you can treat the disease.  Continue reading<a href=\"https:\/\/www.statnews.com\/2023\/07\/16\/alzheimers-disease-crispr-treatments\/\" data-type=\"URL\" data-id=\"https:\/\/www.statnews.com\/2023\/07\/16\/alzheimers-disease-crispr-treatments\/\"> here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"250\" height=\"26\" class=\"wp-image-4372\" style=\"width: 250px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w\" sizes=\"auto, (max-width: 250px) 100vw, 250px\" \/><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:<\/strong>&nbsp;The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Andrew Joseph for STAT) When the genome-editing tool CRISPR is thought of as a potential medicine, the targets that<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26,14],"tags":[116,331,69,94],"class_list":["post-21525","post","type-post","status-publish","format-standard","hentry","category-alzheimersdementia","category-medical-technology","tag-alzheimers-disease","tag-crispr-gene-editing","tag-medical-technology","tag-older-adults"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/21525","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21525"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/21525\/revisions"}],"predecessor-version":[{"id":21526,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/21525\/revisions\/21526"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21525"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21525"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21525"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}